Major depressive disorder (MDD) is an insidious disease and affects up to 15% of the global population. Although MDD responds to a wide range of pharmacological treatment options, a number of factors, i.e. not adhering to treatment for at least 4–12 months, contribute to antidepressants not being highly effective. In an attempt to aid clinicians in improving the adherence rates among MDD patients, the current paper will divulge in more detail the possible explanations of why individuals with MDD find it difficult to adhere to prescribed regimens
<div><p>Background</p><p>One of the major challenges in treating major depressive disorder (MDD) is ...
Major depressive disorder (MDD) is a common and serious illness of our times, associated with monoam...
Background: Evidence suggests that nearly half of patients with major depressive disorder (MDD) do n...
Major depressive disorder (MDD) is an insidious disease and affects up to 15% of the global populati...
Studies conducted in primary care as well as in psychiatric settings show that more than half of pat...
Major depressive disorder (MDD) is a disabling condition with a high frequency of recurrence and non...
Thesis (Master's)--University of Washington, 2015Background: Pharmacotherapy to treat Major Depressi...
BACKGROUND: One of the major challenges in treating major depressive disorder (MDD) is patients' non...
PURPOSE: To describe pharmacological treatment patterns in Asian patients with major depressive diso...
14siStudies conducted in primary care as well as in psychiatric settings show that more than half of...
Abstract Background: Patients on antidepressant therapy have no contact with their physicians until...
Published online: 08 Dec 2020Major depressive disorder is a common, recurrent, disabling and costly ...
PhD (Pharmacy Practice), North-West University, Potchefstroom Campus, 2015The main aim of the thesis...
Background:Patients on antidepressant therapy have no contact with their physicians until th...
Text in EnglishPharmacological treatment is often required in the management of psychiatric disorder...
<div><p>Background</p><p>One of the major challenges in treating major depressive disorder (MDD) is ...
Major depressive disorder (MDD) is a common and serious illness of our times, associated with monoam...
Background: Evidence suggests that nearly half of patients with major depressive disorder (MDD) do n...
Major depressive disorder (MDD) is an insidious disease and affects up to 15% of the global populati...
Studies conducted in primary care as well as in psychiatric settings show that more than half of pat...
Major depressive disorder (MDD) is a disabling condition with a high frequency of recurrence and non...
Thesis (Master's)--University of Washington, 2015Background: Pharmacotherapy to treat Major Depressi...
BACKGROUND: One of the major challenges in treating major depressive disorder (MDD) is patients' non...
PURPOSE: To describe pharmacological treatment patterns in Asian patients with major depressive diso...
14siStudies conducted in primary care as well as in psychiatric settings show that more than half of...
Abstract Background: Patients on antidepressant therapy have no contact with their physicians until...
Published online: 08 Dec 2020Major depressive disorder is a common, recurrent, disabling and costly ...
PhD (Pharmacy Practice), North-West University, Potchefstroom Campus, 2015The main aim of the thesis...
Background:Patients on antidepressant therapy have no contact with their physicians until th...
Text in EnglishPharmacological treatment is often required in the management of psychiatric disorder...
<div><p>Background</p><p>One of the major challenges in treating major depressive disorder (MDD) is ...
Major depressive disorder (MDD) is a common and serious illness of our times, associated with monoam...
Background: Evidence suggests that nearly half of patients with major depressive disorder (MDD) do n...